摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,4-dihydroxy-3-methylphenyl)-3,3-dimethylbutan-1-one

中文名称
——
中文别名
——
英文名称
1-(2,4-dihydroxy-3-methylphenyl)-3,3-dimethylbutan-1-one
英文别名
——
1-(2,4-dihydroxy-3-methylphenyl)-3,3-dimethylbutan-1-one化学式
CAS
——
化学式
C13H18O3
mdl
——
分子量
222.284
InChiKey
QBKBWNGCKPWUIM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2,4-dihydroxy-3-methylphenyl)-3,3-dimethylbutan-1-one偶氮二甲酸二叔丁酯三苯基膦 、 sodium hydroxide 作用下, 以 四氢呋喃1,4-二氧六环乙腈 为溶剂, 反应 4.25h, 生成 C23H27FO6
    参考文献:
    名称:
    II 组代谢型谷氨酸受体的正变构调节剂 (PAM):作为离体工具化合物的设计、合成和评估
    摘要:
    这封信描述了在铊通量测定中具有中等 mGlu 3效力和强大 mGlu 2效力的两个系列双 mGlu 2 /mGlu 3正变构调节剂的合成和评估。通过共同应用选择性mGlu 2 NAM 以分离mGlu 3选择性作用,分析了这些化合物调节中枢神经元中mGlu 3介导的信号传导的能力。利用从前额皮质急性小鼠脑切片,组II组mGlu受体激动剂的Ca的增强2+在PFC锥体细胞与双组mGlu信令2 /组mGlu 3 PAM 16E或图23d证明了通过mGlu 3选择性介导的效果。
    DOI:
    10.1016/j.bmcl.2021.128342
  • 作为产物:
    描述:
    3,3-二甲基-1-丁酸 在 aluminum (III) chloride 、 草酰氯 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 生成 1-(2,4-dihydroxy-3-methylphenyl)-3,3-dimethylbutan-1-one
    参考文献:
    名称:
    Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence
    摘要:
    As part of our ongoing small-molecule metabotropic glutamate (mGlu) receptor positive allosteric modulator (PAM) research, we performed structure activity relationship (SAR) studies around a series of group II mGlu PAMs. Initial analogues exhibited weak activity as mGlu(2) receptor PAMs and no activity at mGlu(3). Compound optimization led to the identification of potent mGlu(2/3) selective PAMs with no in vitro activity at mGlu(1,4-8) or 45 other CNS receptors. In vitro pharmacological characterization of representative compound 44 indicated agonist-PAM activity toward mGlu(2) and PAM activity at mGlu(3). The most potent mGlu(2/3) PAMs were characterized in assays predictive of ADME/T and pharmacokinetic (PK) properties, allowing the discovery of systemically active mGlu(2/3) PAMs. On the basis of its overall profile, compound 74 was selected for behavioral studies and was shown to dose-dependently decrease cocaine self-administration in rats after intraperitoneal administration. These mGlu(2/3) receptor PAMs have significant potential as small molecule tools for investigating group II mGlu pharmacology.
    DOI:
    10.1021/jm5000563
点击查看最新优质反应信息

文献信息

  • [EN] METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF<br/>[FR] MODULATEURS ALLOSTÉRIQUES POSITIFS (PAM) DU RÉCEPTEUR MÉTABOTROPIQUE DU GLUTAMATE ET LEURS UTILISATIONS
    申请人:SANFORD BURNHAM MED RES INST
    公开号:WO2015157187A1
    公开(公告)日:2015-10-15
    Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor positive allosteric modulators (PAMS), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
    本文件提供了小分子活性的代谢型谷氨酸亚型-2和-3受体正变构调节剂(PAMS),包括这些化合物的组合物,以及使用这些化合物和包含这些化合物的组合物的方法。
  • Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
    申请人:Pinkerton Anthony B
    公开号:US20080293684A1
    公开(公告)日:2008-11-27
    The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.
    本发明涉及化合物,它们是代谢型谷氨酸受体的增强剂,包括mGluR2受体,可用于治疗或预防与谷氨酸功能障碍相关的神经和精神障碍以及代谢型谷氨酸受体参与的疾病。本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗代谢型谷氨酸受体参与的疾病方面的使用。
  • Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
    申请人:Sanford-Burnham Medical Research Institute
    公开号:US10099993B2
    公开(公告)日:2018-10-16
    Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor positive allosteric modulators (PAMS), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
    本文提供了小分子活性代谢型谷氨酸亚型-2 和-3 受体正异位调节剂(PAMS)、包含这些化合物的组合物以及使用这些化合物和包含这些化合物的组合物的方法。
  • Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-Thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators
    作者:Anthony B. Pinkerton、Rowena V. Cube、John H. Hutchinson、Joyce K. James、Michael F. Gardner、Hervé Schaffhauser、Blake A. Rowe、Lorrie P. Daggett、Jean-Michel Vernier
    DOI:10.1016/j.bmcl.2004.09.028
    日期:2004.12
    We have identified and synthesized a series of 4-thiopyridyl acetophenones as positive allosteric potentiators of the metabotropic glutamate receptor 2. Structure-activity relationship studies directed toward replacement of the tetrazole in the initial lead led to the discovery of 16 (EC50 = 340 nM), which showed improved brain penetration over the initial lead. (C) 2004 Elsevier Ltd. All rights reserved.
  • HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS
    申请人:Merck & Co., Inc.
    公开号:EP1773774A2
    公开(公告)日:2007-04-18
查看更多